中英对照:加国疫苗接种战:起了个大早 赶了个晚集
Ottawa's inoculation campaign has let Canadians down
来源: 大中报 南茜(Nancy Jin)
联邦政府早在2020年12月份就对疫苗购置成果沾沾自喜,宣称加拿大取得了全球疫苗竞赛中的早期胜利 。但三个月后,加拿大在疫苗接种方面被世界30多个国家远远甩在后面,其疫苗接种率甚至不如智利和摩洛哥等发展中国家。的确, 踌躇满志的加国政府很早就着手为加国人士购置疫苗,在没有一家药厂宣布疫苗中期测试结果之前就在疫苗市场上流连忘返,精心挑选潜在的疫苗候选产品。但是什么原因让加拿大在疫苗接种战中起了个大早,却赶了个晚集?
In Dec. 2020, Ottawa boasted one of the best vaccine portfolios of any country in the world, claiming an early victory in the global vaccination race. But three months later, Canada found itself losing badly in the competition, defeated by 30 countries in vaccination rates, including the developing nations such as Chile and Morocco. Indeed, the enthusiastic Liberal government had early planning for Canada's inoculation drive. Ottawa started to shop on the vaccine market, seeking potential candidates well before any vaccine products released clinical trial results. But what has caused Canada, an early bird runner, to fail stunningly in the vaccination campaign?
今天你也许关心的话题:
想要阅读与本文有关的话题?请点击本文末的链接!
加拿大国家研究委员会与中国康希诺生物制药厂的合资项目就是联邦政府在疫苗计划中的第一手败笔。联邦政府在疫情初期就对与作为全球“救世主”的中国联手抱有极大幻想,认为与中国的这家药厂的合作是加拿大打赢这场疫苗战的契机。联邦政府批准了这项疫苗合作计划,并在去年5月斥资数千万元改造国家研究委员会的疫苗生产设施以生产合资疫苗。 但联邦政府却押错了宝,看走了眼,对合作项目中从地域政治到科学系统内所暗藏的种种危险因素一无所知,毫无察觉。
A joint venture project between NRC (National Research Council) and CanSino Biologics marked the first missteps in Ottawa's vaccination journey. Ottawa seemed to hold a firm belief at the beginning of the pandemic that a partnership with China, the savior of the world, would bring a vaccination frontrunner story for Canadians. It has approved the joint venture project in early May and doled out tens of millions of dollars to turn an NRC facility into SinoVac's vaccine producer. However, Ottawa placed an ill-fated bet on the Chinese vaccine maker, being ignorant to multiple lurking factors that threatened the deal's survival – from geopolitics to science.
分享不同信息/观点,做明智判断/决策!请点击096.ca!
分享不同信息/观点,做明智判断/决策!请点击096.ca!
中国政府突然改变了疫苗合作战略,并策划通过在第三世界国家获得软实力来击败西方竞争对手。就在联合项目签署的第三天,中国海关突然扣押了运往加国的疫苗种子。中国政府决定不再与加拿大合作进行疫苗临床试验,而是转向巴基斯坦,俄国,墨西哥和智利等国招募临床测试志愿者。但即使这项合作计划如期在加国进行,其疫苗开发原理以及其二等疫苗身份会使加拿大陷入更被动的局面,让联邦政府更为尴尬窘迫。事实上,康希诺在今年2月份宣布其三期临床65.7%的有效率时,全球已有几亿人口接种了辉瑞和摩多纳的疫苗。
Beijing suddenly changed its partnership strategy, trying to supplant Western rivals by gaining soft power in the third world countries. Three days after NRC formed the partnership with CanSino, Chinese customs banned the shipment of CanSino's vaccine seeds from leaving the Chinese shore. Instead of recruiting Canadians for clinical trials, Beijing turned to Pakistan, Russia, Mexico, and Chile for trial participants. But had the joint venture proceeded in Canada as planned, its outdated vaccine model and its second-tier product status would have only left Canada worse off and Ottawa more embarrassed. As it turned out when CanSino announced its Phase III trial results of 65.7% efficacy in Feb.2021, a sharp contrast to 95% of Pfizer and Moderna, over 100 million people around the world had already received Pfizer and Moderna vaccine shots.
与中国的合资项目失败后,惊慌失措的联邦政府大肆购置疫苗产品,与辉瑞和摩多纳签署了足够接种三倍加国人士的疫苗购买协定。但是,这个所谓的“疫苗囤积国”却货不到位,疫苗迟迟不入加国口岸,眼睁睁地看着加国人士种不上疫苗。至二月下旬,加拿大仅仅收到140万款疫苗,每100人接种率仅为3人,屈居全球第50位,远远落后于英国的21人和美国的14人。
After the collapse of the joint venture with China, Ottawa frantically embarked on a vaccine shopping spree, purchasing enough vaccines from Pfizer and Moderna to inoculate Canadians three times over. However, the "vaccine contract hoarder" struggled to get its hands on the doses and get jabs into Canadian arms. By late Feb., Canada had received over 1.4 million doses, putting it the 50th in the world of doses per 100 people. Its vaccination rate was three out of 100, lagging far behind the UK of 21 and the US of 14.
渥太华政府在疫苗采购过程中出现了多项重大失误。缺乏本土疫苗生产能力,疫苗合同中未制定优先供货条款,而是规定按季交货,不敢公开疫苗合同以掩盖失误,且招募的疫苗行动专家小组中有一半都与疫苗厂家有染等都是导致加拿大在疫苗接种战惨败的直接原因。
A series of significant flaws appeared in Ottawa's vaccine procurement process. Lacking domestic vaccine production capacity, failing to negotiate a priority shipment, rather than a quarterly delivery, keeping the vaccine contract secret in an attempt to hide missteps, and recruiting a vaccine task force, with half of the members having connections to firms in the vaccine field, are all contributing factors for Canada's disastrous outcome.
分享不同信息/观点,做明智判断/决策!请点击096.ca!
分享不同信息/观点,做明智判断/决策!请点击096.ca!
联邦政府的疫苗失误让加国人士倍感失望。 在全球如火如荼地开展着疫苗接种战的今天,他们需要的是一个有优秀领导能力的,不仅有意愿服务于加国人士,且有能力带领加国人士打赢这场疫苗接种战的联邦政府。毋庸置疑,加国选民会在选出下一届政府时认真考虑自由党政府在疫苗战中的表现。
Ottawa's vaccine failure has let Canadians down. They need a superior leadership as the global vaccination race heats up, expecting a government to have both a desire to serve and the ability to deliver. Undoubtedly, Canadians will put the Liberal government's inoculation campaign under tightened scrutiny as they choose the next government.
网友评论
网友评论仅供其表达个人看法,并不表明大中资讯网立场。评论不可涉及非法、粗俗、猥亵、歧视,或令人反感的内容,本网站有权删除相关内容。